Aerpio raises $18 million in A-2 round

Aerpio Therapeutics Inc. (Cincinnati, Ohio) raised $18 million in a series A-2 round led by new investor OrbiMed. Existing investors Novartis Venture Funds; Satter Investment Management; Kearny Venture Partners; Venture Investors; Triathlon Medical Ventures; and Athenian Venture Partners also participated. OrbiMed's Chau Khuong will join Aerpio's board. ...